curasan AG receives license for Osbone

11-Dec-2009 - Germany

curasan AG has received CE certification and, therefore, marketing authorization throughout Europe of the synthetic bone replacement material Osbone®. Osbone® is suitable for utilisation in general bone surgery, particularly in implantology and oral and maxillofacial surgery associated with jawbone atrophy.

Hans Dieter Rössler, CEO of curasan AG, explains the advantage of the new product: “Just like the absorbable Cerasorb®, which has already been launched, Osbone® is 100% synthetic and offers practitioners as well as patients the guarantee that the material itself will not result in any adverse effects.“

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances